DORA PSI | Digital Object Repository at PSI

Export As:

Style

Style

Search Results 1 - 20 of 23

Sort

	Select Page
	Design and evaluation of novel albumin-binding folate radioconjugates: systematic approach of varying the linker entities Benešová, M., Guzik, P., Deberle, L. M., Busslinger, S. D., Landolt, T., Schibli, R., & Müller, C. (2022). Design and evaluation of novel albumin-binding folate radioconjugates: systematic approach of varying the linker entities. Molecular Pharmaceutics, 19, 963-973. https://doi.org/10.1021/acs.molpharmaceut.1c00932 Detailed Record Published Version Accepted Version
	Novel synthetic strategies enable the efficient development of folate conjugates for cancer radiotheranostics Deberle, L. M., Benešová, M., Becker, A. E., Ratz, M., Guzik, P., Schibli, R., & Müller, C. (2021). Novel synthetic strategies enable the efficient development of folate conjugates for cancer radiotheranostics. Bioconjugate Chemistry, 32(8), 1617-1628. https://doi.org/10.1021/acs.bioconjchem.1c00198 Detailed Record Published Version Accepted Version
	Identification of a PET radiotracer for imaging of the folate receptor-α: a potential tool to select patients for targeted tumor therapy Guzik, P., Fang, H. Y., Deberle, L. M., Benešová, M., Cohrs, S., Boss, S. D., … Müller, C. (2021). Identification of a PET radiotracer for imaging of the folate receptor-α: a potential tool to select patients for targeted tumor therapy. Journal of Nuclear Medicine, 62(10), 1475-1481. https://doi.org/10.2967/jnumed.120.255760 Detailed Record Published Version Accepted Version
	Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates - new perspectives for folate receptor-targeted radionuclide therapy Guzik, P., Benešová, M., Ratz, M., Monné Rodríguez, J. M., Deberle, L. M., Schibli, R., & Müller, C. (2021). Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates - new perspectives for folate receptor-targeted radionuclide therapy. European Journal of Nuclear Medicine and Molecular Imaging, 48, 972-983. https://doi.org/10.1007/s00259-020-04980-y Detailed Record Published Version
	Biodistribution and dosimetry of a single dose of albumin-binding ligand [<sup>177</sup>Lu]Lu-PSMA-ALB-56 in patients with mCRPC Kramer, V., Fernández, R., Lehnert, W., Jiménez-Franco, L. D., Soza-Ried, C., Eppard, E., … Müller, C. (2021). Biodistribution and dosimetry of a single dose of albumin-binding ligand [¹⁷⁷Lu]Lu-PSMA-ALB-56 in patients with mCRPC. European Journal of Nuclear Medicine and Molecular Imaging, 48, 893-903. https://doi.org/10.1007/s00259-020-05022-3 Detailed Record Published Version
	Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity Deberle, L. M., Benešová, M., Umbricht, C. A., Borgna, F., Büchler, M., Zhernosekov, K., … Müller, C. (2020). Development of a new class of PSMA radioligands comprising ibuprofen as an albumin-binding entity. Theranostics, 10(4), 1678-1693. https://doi.org/10.7150/thno.40482 Detailed Record Published Version
	Internal radiation dosimetry of a <sup>152</sup>Tb-labeled antibody in tumor-bearing mice Cicone, F., Gnesin, S., Denoël, T., Stora, T., van der Meulen, N. P., Müller, C., … Prior, J. O. (2019). Internal radiation dosimetry of a ¹⁵²Tb-labeled antibody in tumor-bearing mice. EJNMMI Research, 9, 53 (10 pp.). https://doi.org/10.1186/s13550-019-0524-7 Detailed Record Published Version
	Preclinical investigations and first-in-human application of <sup>152</sup>Tb-PSMA-617 for PET/CT imaging of prostate cancer Müller, C., Singh, A., Umbricht, C. A., Kulkarni, H. R., Johnston, K., Benešová, M., … Baum, R. P. (2019). Preclinical investigations and first-in-human application of ¹⁵²Tb-PSMA-617 for PET/CT imaging of prostate cancer. EJNMMI Research, 9(1), 68 (10 pp.). https://doi.org/10.1186/s13550-019-0538-1 Detailed Record Published Version
	New <sup>55</sup>Co-labeled albumin-binding folate derivatives as potential PET agents for folate receptor imaging Radford, L. L., Fernandez, S., Beacham, R., Sayed, R. E., Farkas, R., Benešová, M., … Lapi, S. E. (2019). New ⁵⁵Co-labeled albumin-binding folate derivatives as potential PET agents for folate receptor imaging. Pharmaceuticals, 12(4), 166 (12 pp.). https://doi.org/10.3390/ph12040166 Detailed Record Published Version
	<sup>18</sup>F-AzaFol for detection of folate receptor-β positive macrophages in experimental interstitial lung disease - a proof-of-concept study Schniering, J., Benešová, M., Brunner, M., Haller, S., Cohrs, S., Frauenfelder, T., … Maurer, B. (2019). ¹⁸F-AzaFol for detection of folate receptor-β positive macrophages in experimental interstitial lung disease - a proof-of-concept study. Frontiers in Immunology, 10, 2724 (15 pp.). https://doi.org/10.3389/fimmu.2019.02724 Detailed Record Published Version
	Implementation of a new separation method to produce qualitatively improved <sup>64</sup>Cu van der Meulen, N. P., Hasler, R., Blanc, A., Farkas, R., Benešová, M., Talip, Z., … Schibli, R. (2019). Implementation of a new separation method to produce qualitatively improved ⁶⁴Cu. Journal of Labelled Compounds and Radiopharmaceuticals, 62(8), 460-470. https://doi.org/10.1002/jlcr.3730 Detailed Record Published Version
	Albumin-binding PSMA ligands: optimization of the tissue distribution profile Benešová, M., Umbricht, C. A., Schibli, R., & Müller, C. (2018). Albumin-binding PSMA ligands: optimization of the tissue distribution profile. Molecular Pharmaceutics, 15(3), 934-946. https://doi.org/10.1021/acs.molpharmaceut.7b00877 Detailed Record Published Version
	In vivo labeling of plasma proteins for imaging of enhanced vascular permeability in the lungs Schniering, J., Borgna, F., Siwowska, K., Benešová, M., Cohrs, S., Hasler, R., … Müller, C. (2018). In vivo labeling of plasma proteins for imaging of enhanced vascular permeability in the lungs. Molecular Pharmaceutics, 15(11), 4995-5004. https://doi.org/10.1021/acs.molpharmaceut.8b00606 Detailed Record Published Version
	Visualisation of interstitial lung disease by molecular imaging of integrin αvβ3 and somatostatin receptor 2 Schniering, J., Benešová, M., Brunner, M., Haller, S., Cohrs, S., Frauenfelder, T., … Maurer, B. (2018). Visualisation of interstitial lung disease by molecular imaging of integrin αvβ3 and somatostatin receptor 2. Annals of the Rheumatic Diseases, 78(2), 218-227. https://doi.org/10.1136/annrheumdis-2018-214322 Detailed Record Published Version Erratum
	Design and preclinical evaluation of an albumin-binding PSMA ligand for <sup>64</sup>Cu-based PET imaging Umbricht, C. A., Benešová, M., Hasler, R., Schibli, R., van der Meulen, N. P., & Müller, C. (2018). Design and preclinical evaluation of an albumin-binding PSMA ligand for ⁶⁴Cu-based PET imaging. Molecular Pharmaceutics, 15(12), 5556-5564. https://doi.org/10.1021/acs.molpharmaceut.8b00712 Detailed Record Published Version
	Preclinical development of novel PSMA-targeting radioligands: modulation of albumin-binding properties to improve prostate cancer therapy Umbricht, C. A., Benešová, M., Schibli, R., & Müller, C. (2018). Preclinical development of novel PSMA-targeting radioligands: modulation of albumin-binding properties to improve prostate cancer therapy. Molecular Pharmaceutics, 15(6), 2297-2306. https://doi.org/10.1021/acs.molpharmaceut.8b00152 Detailed Record Published Version
	Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with <sup>152</sup>Tb-DOTATOC Baum, R. P., Singh, A., Benešová, M., Vermeulen, C., Gnesin, S., Köster, U., … Müller, C. (2017). Clinical evaluation of the radiolanthanide terbium-152: first-in-human PET/CT with ¹⁵²Tb-DOTATOC. Dalton Transactions, 46(42), 14638-14646. https://doi.org/10.1039/c7dt01936j Detailed Record Published Version
	<sup>47</sup>Sc as useful β<sup>–</sup>-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes Domnanich, K. A., Müller, C., Benešová, M., Dressler, R., Haller, S., Köster, U., … van der Meulen, N. P. (2017). ⁴⁷Sc as useful β^–-emitter for the radiotheragnostic paradigm: a comparative study of feasible production routes. EJNMMI Radiopharmacy and Chemistry, 2, 5 (17 pp.). https://doi.org/10.1186/s41181-017-0024-x Detailed Record Published Version
	Glu-ureido-based inhibitors of prostate-specific membrane antigen: lessons learned during the development of a novel class of low-molecular-weight theranostic radiotracers Kopka, K., Benešová, M., Bařinka, C., Haberkorn, U., & Babich, J. (2017). Glu-ureido-based inhibitors of prostate-specific membrane antigen: lessons learned during the development of a novel class of low-molecular-weight theranostic radiotracers. Journal of Nuclear Medicine, 58(Suppl. 2), 17S-26S. https://doi.org/10.2967/jnumed.116.186775 Detailed Record Published Version
	Synthesis, radiolabeling, and characterization of plasma protein-binding ligands: potential tools for modulation of the pharmacokinetic properties of (radio)pharmaceuticals Müller, C., Farkas, R., Borgna, F., Schmid, R. M., Benešová, M., & Schibli, R. (2017). Synthesis, radiolabeling, and characterization of plasma protein-binding ligands: potential tools for modulation of the pharmacokinetic properties of (radio)pharmaceuticals. Bioconjugate Chemistry, 28(9), 2372-2383. https://doi.org/10.1021/acs.bioconjchem.7b00378 Detailed Record Published Version